Stay updated on NKTR-214 Plus Nivolumab in Sarcoma Clinical Trial
Sign up to get notified when there's something new on the NKTR-214 Plus Nivolumab in Sarcoma Clinical Trial page.

Latest updates to the NKTR-214 Plus Nivolumab in Sarcoma Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedUpdated operating-status notice and metadata: new warning about funding lapse and current status, plus a new 2025-10-01 timestamp and revision v3.2.0, replacing the previous 2025-05-07/08 references and revision v3.1.0.SummaryDifference3%
- Check20 days agoChange Detected- Updated version from v3.0.2 to v3.1.0. - No other content changes detected.SummaryDifference0.1%
- Check27 days agoNo Change Detected
- Check35 days agoChange DetectedRevision updated to v3.0.2, and the Back to Top element was removed.SummaryDifference0.2%
- Check42 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.SummaryDifference0.2%
- Check49 days agoChange DetectedThe web page has undergone significant updates, including the addition of a facility name and location, as well as various new scientific terms related to proteins and antibodies. Notably, previous references to specific locations and certain medical agents have been removed.SummaryDifference2%
- Check63 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%
Stay in the know with updates to NKTR-214 Plus Nivolumab in Sarcoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the NKTR-214 Plus Nivolumab in Sarcoma Clinical Trial page.